Search company, investor...

IVREA Pharmaceuticals

Founded Year



Unattributed VC - II | Alive

Total Raised


Last Raised

$11M | 16 yrs ago

About IVREA Pharmaceuticals

IVREA Pharmaceuticals is a specialty pharmaceutical company focused on clinical development and commercialization of novel prescription pharmaceuticals for the treatment of dermatologic conditions. IVREA's pharmaceuticals leverage topical delivery technologies.

Headquarters Location

216 Ricciuti Drive

Quincy, Massachusetts, 02169,

United States


Missing: IVREA Pharmaceuticals's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: IVREA Pharmaceuticals's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing IVREA Pharmaceuticals

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

IVREA Pharmaceuticals is included in 1 Expert Collection, including Biopharma Tech.


Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

IVREA Pharmaceuticals Frequently Asked Questions (FAQ)

  • When was IVREA Pharmaceuticals founded?

    IVREA Pharmaceuticals was founded in 2005.

  • Where is IVREA Pharmaceuticals's headquarters?

    IVREA Pharmaceuticals's headquarters is located at 216 Ricciuti Drive, Quincy.

  • What is IVREA Pharmaceuticals's latest funding round?

    IVREA Pharmaceuticals's latest funding round is Unattributed VC - II.

  • How much did IVREA Pharmaceuticals raise?

    IVREA Pharmaceuticals raised a total of $16.1M.

  • Who are the investors of IVREA Pharmaceuticals?

    Investors of IVREA Pharmaceuticals include Easton Capital, Atlas Venture and CHL Medical Partners.

  • Who are IVREA Pharmaceuticals's competitors?

    Competitors of IVREA Pharmaceuticals include Acura Pharmaceuticals, Aegerion Pharmaceuticals, OcuCure Therapeutics, Solasia Pharma, PrevaCept Infection Control, Napo Pharmaceuticals, Questcor Pharmaceuticals, Acton Pharmaceuticals, Conatus Pharmaceuticals, ANI Pharmaceuticals and 24 more.

Compare IVREA Pharmaceuticals to Competitors

ENTRA Pharmaceuticals

ENTRA Pharmaceuticals is a specialty pharmaceutical company developing therapies and improving existing treatments in areas with high unmet medical needs. In addition to the company's technology platform, ENTRA possesses strong expertise in preclinical and clinical drug development and commercialization.

Frio Pharmaceuticals

Frio Pharmaceuticals is dedicated to oral-systemic health and was spun out of Biomedical Development Corporation (BDC), its research affiliate, in 1999 to manufacture and sell a dental waterline cleaner. This platform technology has evolved into a pipeline of pharmaceuticals to treat oral diseases and interrupt the disease process. Its goal is to commercialize a broad-spectrum antimicrobial platform technology with products being: (1) a pharmaceutical to treat thrush (oral candidiasis) in cancer patients with thrush and (2) a pharmaceutical to treat gingivitis (oral inflammation).

Advent Pharmaceuticals

Advent Pharmaceuticals is a specialty pharmaceutical company focused on developing inhaled drug products using a dry powder inhalation delivery system. The products are mostly used for the treatment of asthma and other respiratory diseases.

Meditrina Pharmaceuticals

Meditrina Pharmaceuticals, Inc. is a clinical-stage, specialty pharmaceutical company focused on developing and commercializing therapies that treat women's reproductive system disorders, with an initial focus on gynecologic and aromatase-mediated conditions with serious unmet medical needs.

SpePharm Holding

A European specialty pharmaceutical company dedicated to hospital and specialist drugs.SpePharm is a European specialty pharmaceutical company focused on acquiring, registering and marketing high medical value specialty medicines, essentially for the hospital market.

Kytogenics Pharmaceuticals Limited

Kytogenics is a medical device company. It had developed the Nocc Hydrophilic Wound Dressing.Kytogenics Pharmaceuticals, Inc. is a biomedical company engaged in the development of products based on its medical device and drug delivery patented platform technology.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.